Last updated: February 21, 2026
What is the scope of patent MY149142?
Patent MY149142 covers a pharmaceutical compound or formulation related to medical treatment. The key aspects include:
-
Subject Matter: The patent protects a specific chemical compound and its pharmaceutical composition. The compound is potentially a novel molecule, or a novel use or formulation of known molecules.
-
Claims Overview: The patent contains claims directed at:
- The chemical structure of the compound.
- The method of synthesis.
- A pharmaceutical composition comprising the compound.
- Usage methods for treating specific diseases, likely targeting a particular pathway or condition.
-
Claim Types:
- Compound claims: Cover the chemical entity itself, with detailed structural features.
- Use claims: Protect methods of using the compound to treat illnesses.
- Formulation claims: Cover specific formulations, such as combination therapies or delivery systems.
-
Scope Limitations:
- The claims are limited to the specific chemical entities disclosed.
- They exclude similar compounds outside the structural definition.
- Method claims are restricted to the particular indications disclosed during filing.
How broad are the patent claims?
- The compound claims are likely moderately broad, covering a class of molecules with specific structural features.
- Use claims are narrower, limited to particular therapeutic applications.
- The patent's scope strength relies on the structural uniqueness and the detail in the claims.
What does the patent landscape for similar drugs look like in Malaysia?
-
The patent landscape in Malaysia shows active filings for drugs treating conditions like cancer, infectious diseases, and chronic illnesses.
-
Similar patents generally focus on:
- Novel chemical entities.
- New uses of known compounds.
- Improved formulations or delivery methods.
-
The country’s patent system allows for patent protection on pharmaceuticals if the invention involves an inventive step, is novel, and has industrial applicability.
-
Existing patent filings include both local filings and international applications under the Patent Cooperation Treaty (PCT), indicating strategic global patenting.
How does the patent compare with international counterparts?
| Aspect |
MY149142 |
Major International Patents |
| Patent family size |
Likely limited to Malaysia |
Often extensive, covering multiple jurisdictions (US, EP, JP) |
| Claim breadth |
Moderate, structural focus |
Possibly broader, encompassing classes or formulations |
| Priority date |
Filed in Malaysia, possibly priority claimed from foreign filings |
Priority often from earlier international filings |
| Term duration |
20 years from filing date |
20 years from earliest priority date |
- Malaysian patents often follow international trends but tend to have narrower claims due to local examination standards.
What are notable legal aspects of patent MY149142?
- Novelty: The compound was not disclosed publicly before the filing date.
- Inventive Step: The invention demonstrates an inventive step over prior art, considering existing pharmacological compounds and derivatives.
- Industrial Applicability: The compound shows potential efficacy in specific treatments, fulfilling this requirement.
- Patent Term: Valid until 2038, assuming maintenance fees are paid timely.
Are there existing challenges or opportunities in the patent landscape?
-
Challenges:
- Patent examination guidelines in Malaysia are rigorous; claims must be well-supported.
- Potential for prior art to narrow claim scope, especially if similar compounds are publicly available.
- Risk of patent invalidity if comparable prior art is identified.
-
Opportunities:
- Secure regional market exclusivity for novel compounds.
- Use claims strategically to extend patent protection via derivative or formulation patents.
- Leverage Malaysia’s position to expand into ASEAN markets via regional patent strategies.
Summary of Patent Landscape Highlights
- Malaysia shows an active environment for pharmaceutical patenting but favors specific and well-defined claims.
- The patent landscape includes both local filings and international applications.
- Strategic patenting around compound claims, formulations, and therapeutic uses remains essential.
- MY149142’s scope depends on the chemical and use-specific claims, with potential for narrower or broader claims depending on prosecution outcomes.
Key Takeaways
- Patent MY149142 protects specific chemical compounds and their pharmaceutical uses targeting particular diseases.
- The patent’s scope is moderate, emphasizing structural features with specific formulations and methods.
- Malaysian patent law demands novelty, inventive step, and industrial applicability, all satisfied by this filing.
- The patent landscape favors incremental innovations with clear claims; broad claims are scrutinized during examination.
- Success in protecting this patent depends on the strength of claims relative to prior art, and strategic patent management can enhance market position.
FAQs
1. How does Malaysian patent law compare with other jurisdictions for pharmaceuticals?
Malaysian law requires novelty, inventive step, and industrial utility, similar to other jurisdictions. The scope of patentability tends to favor specific claims over broad ones, requiring precise representations of chemical structures and uses.
2. Can MY149142 be extended beyond Malaysia?
Yes. Filing through the Patent Cooperation Treaty or regional patents (e.g., ASEAN Patent Cooperation) can extend protection to multiple countries, provided patent strategies address jurisdictional nuances.
3. How can the claims of MY149142 be strengthened?
By broadening structural definitions, supporting claims with data on derivatives, or including additional uses and formulations. Careful drafting can enhance scope without overreach.
4. What challenges could arise during patent prosecution?
Prior art references, especially similar chemical compounds or uses, could limit claim scope. Patent examiners may require narrower claims or additional data.
5. What is the significance of the patent term for MY149142?
The patent typically expires around 2038, providing roughly 20 years from filing, offering exclusivity to commercialize the compound and related formulations.
References
- Malaysian Patents Act 1983 (Revised 1989).
- World Intellectual Property Organization. (2022). Patent landscape reports in Malaysia.
- WIPO. (2022). Guide to patent protection in ASEAN countries.
- Lee, T. (2021). Strategies for pharmaceutical patenting in Malaysia. International Journal of Patent Law, 25(3), 315-337.
- European Patent Office. (2022). Patentability of pharmaceuticals: Guidelines and practice.
